F.D.A. Delays Clinical Trial of Embryonic Stem Cells
 

F.D.A. Delays Clinical Trial of Embryonic Stem Cells

By BLOOMBERG NEWS
Published: May 15, 2008

The Geron Corporation announced Wednesday that its plans to begin the first clinical trial using embryonic stem cells had been delayed by federal regulators.

The company, based in Menlo Park, Calif., had planned to begin a human trial soon to test its stem cell compound in patients with spinal cord injuries.

The company received oral notice about the delay from the Food and Drug Administration on Wednesday and is awaiting a letter from the agency explaining its decision, said Geron’s chief executive, Thomas B. Okarma.

READ all...